AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 35(2), 1986, pp. 259-262
Copyright © 1986 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strickland, G. T.
Right arrow Articles by Macdonald, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strickland, G. T.
Right arrow Articles by Macdonald, M.

Effects of Chloroquine, Amodiaquine and Pyrimethamine-Sulfadoxine on Plasmodium Falciparum Gametocytemia

G. Thomas Strickland, Emile Fox, Mohammad Sarwar, Amir A. Khaliq AND Michael Macdonald
Clinical Epidemiology Department, International Center for Medical Research and Training, Lahore, Pakistan, and International Health Program, University of Maryland School of Medicine, Baltimore, Maryland 21201

The effects of chloroquine, amodiaquine and pyrimethamine-sulfadoxine (SP) (Fansidar) on the infection rate and density of Plasmodium flaciparum gametocytes were studied in 198 patients with falciparum malaria from an area in the Punjab where malaria is endemic but seasonally transmitted. One month following treatment of 100 patients, SP had reduced the gametocyte carrier rate from 37% to 6% and the mean gametocyte density from 80 to 1.4 per mm3 of blood. Chloroquine and amodiaquine were much less effective. Since SP has no gametocytocidal properties and the reduction in gametocytes coincided with clearance of asexual parasitemias, gametocytes were probably reduced subsequent to the cure of the asexual malaria infections. If used during the nontransmission season, SP might be an effective component of an integrated program for reducing malaria transmission in the Punjab and other areas where 4-aminoquinoline-resistant and SP-sensitive falciparum malaria exists.

Accepted for publication September 25, 1985.




This article has been cited by other articles:


Home page
J Clin PharmacolHome page
J. P. Daily
Antimalarial drug therapy: the role of parasite biology and drug resistance.
J. Clin. Pharmacol., December 1, 2006; 46(12): 1487 - 1497.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American Society of Tropical Medicine and Hygiene.